Trends in Chronic Kidney Disease in China.

By Luxia Zhang, Jianyan Long, Wenshi Jiang, Ying Shi, Xiangxiang He, Zhiye Zhou, Yanwei Li, R. Yeung, Jinwei Wang, K. Matsushita and 3 more. New England Journal of Medicine, 2016

644 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Nephrology

View Paper: https://www.semanticscholar.org/paper/ea166dd5c66bf5824d72142f6d95f67bd3ff77bd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Kai-Uwe Eckardt
2. R. Mehta
3. B. Kasiske

In Nephrology

1. A. Levey
2. Josef Coresh
3. Marcello Tonelli
4. Harold I. Feldman
5. A. Levin
6. R. Gansevoort
7. Giuseppe Remuzzi
8. R. Mehta

Citations in the corpus

• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. (2017, background): “For example, a recent publication from China showed that among 19 million tertiary hospital discharges, the prevalence of CKD due to diabetes is now higher than the prevalence of GN (substantially different than the situation a decade ago).(155) When EMRs include laboratory data, researchers can app”
• Standards of medical care for type 2 diabetes in China 2019 (2019, background): “Approximately 20% to 40% of diabetic patients suffer from diabetic kidney disease in China, which is the main cause of CKD and end‐stage renal failure in patients with diabetes.(111,112) 3 3a Mild to moderate GFR decrease 45‐59 3b Moderate to severe GFR decrease 30‐44”